PhagePro, Inc.

PhagePro, Inc. is a public benefit corporation focused on developing phage treatments for bacterial diseases and addressing antibiotic resistance. The company brings together phage and bacteria experts with public policy, industry, commercialization, and community stakeholders. Its website identifies a lead program focused on cholera and highlights health equity and access as central goals. Available information does not specify the program’s development stage or regulatory status.